LYRA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3626 USD | -2.66% |
|
-30.47% | -93.08% |
| 07/05 | Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50 | MT |
| 07/05 | HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 22.71M | - | - | - | |||
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
